Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol MN1 contributors: mct/npt - updated : 14-01-2020
HGNC name meningioma (disrupted in balanced translocation) 1
HGNC id 7180
Corresponding disease
DDDFD developmental delay, dolichocephaly, facial dysmorphism
MN1 meningioma 1, familial
Location 22q12.1      Physical location : 28.144.265 - 28.197.486
Synonym name
  • meningioma chromosome region
  • probable tumor suppressor protein MN1
  • bK437G10B.1 (meningioma (disrupted in balanced translocation) 1)
  • Synonym symbol(s) MGCR1, MGCR, MGCR1-PEN, dJ353E16.2
    DNA
    TYPE functioning gene
    STRUCTURE 53.48 kb     2 Exon(s)
    10 Kb 5' upstream gene genomic sequence study
    regulatory sequence Promoter
    text structure a CACCC-containing sequence, located 140 bp upstream of the transcription start site of the promoter, is required for MN1 action (Meester-Smoor 2007)
    MAPPING cloned Y linked N status provisional
    RNA
    TRANSCRIPTS type messenger
    identificationnb exonstypebpproduct
    ProteinkDaAAspecific expressionYearPubmed
    2 - 7814 136 1320 - 2017 27983532
    EXPRESSION
    Type ubiquitous
       expressed in (based on citations)
    organ(s)
    SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
    Nervousbrain   highly Homo sapiensFetal
    Respiratorylung   highly
    Urinarykidney   highly
    tissue
    SystemTissueTissue level 1Tissue level 2LevelPubmedSpeciesStageRna symbol
    Muscularstriatumskeletal   Homo sapiensAdult
    Muscularstriatumskeletal   Homo sapiensFetal
    cell lineage
    cell lines
    fluid/secretion
    at STAGE
    PROTEIN
    PHYSICAL PROPERTIES
    STRUCTURE
    motifs/domains
  • N-terminal nuclear localization signal,
  • proline-rich sequences,
  • two polyglutamine stretches
  • multiple transcription activating domains
  • C-terminal region of MN1 is required for degradation through the ubiquitin-proteasome pathway
  • HOMOLOGY
    interspecies homolog to C.elegans F13D12.4
    Homologene
    FAMILY
    CATEGORY tumor suppressor
    SUBCELLULAR LOCALIZATION
    basic FUNCTION
  • may be playing a role in tumor suppression
  • activates the transcription activity of the moloney sarcoma virus long terminal repeat, indicating that this protein itself may act as a transcription factor (Van Wely 2003)
  • may stimulate RAR/RXR-mediated transcription through interaction with EP300 (Van Wely 2003)
  • transcriptional co-activator and oncoprotein which activates transcription of the IGFBP5 promoter through a CACCC-rich consensus sequence (Meester-Smoor 2007)
  • MN1 plays a critical role in human craniofacial and brain development
  • MN1 plays a role in transcriptional regulation through interaction with the DNA-binding transcription factors PBX1 and PKNOX1
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule
    protein
  • MN1 participates in transcriptional regulation of target genes through interaction with the transcription factors PBX1, PKNOX1, and ZBTB24
  • cell & other
    REGULATION
    ASSOCIATED DISORDERS
    corresponding disease(s) MN1 , DDDFD
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral fusion      
    MN1TEL, a leukemia-related fusion protein containing parts of the MN1 and TEL (ETV6) genes (Meester-Smoor 2007)
    tumoral     --over  
    in certain types of human acute myeloid leukemia (Grosveld 2007)
    tumoral     --other  
    aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia (Kuang 2008)
    tumoral     --over  
    contribute to poor colorectal cancer (CRC) prognosis
    constitutional     --over  
    induces proliferation and represses myeloid differentiation of primitive hematopoietic cells
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
  • can serve as a novel potential biomarker in predicting the prognosis of colorectal cancer (CRC) patients
  • Therapy target
    ANIMAL & CELL MODELS